Streetbeat News

Products Services

BFRG

Bullfrog AI Holdings has announced that the United States Patent and Trademark Office will issue U.S. Patent No. 11,712,435 on August 1, 2023. The patent protects the company's novel prodrugs derived from Mebendazole and their use in treating cancers and other diseases.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:56 am

FXI

SPY

TikTok is planning to launch a new e-commerce program in the U.S. in early August, which will sell made-in-China goods. This move could potentially increase competition in the e-commerce sector.

Portfolio Pulse from Charles Gross

July 25, 2023 | 11:40 am

CRVL

Symbeo, a subsidiary of CorVel Corporation, has launched a new Payments solution as part of its Accounts Payable Invoice Automation offering. The product, developed in partnership with Corpay, aims to streamline the payment process, expand working capital, and reduce costs by eliminating manual processes.

Portfolio Pulse from Charles Gross

July 25, 2023 | 11:25 am

GM

GOOGL

MRNA

MS

TSLA

TWTR

Morgan Stanley strategist admits being wrong about the market rally but points to potential headwinds. Alphabet, General Motors, and three other stocks are highlighted for Tuesday. Ark Investment Management identifies Tesla's growth catalysts and buys more Moderna shares. Dogecoin surges after Elon Musk's Twitter rebranding. BlackRock's ETF could boost Bitcoin price. Microsoft and Nvidia are expected to report higher earnings. Tesla discusses low-cost car with Indian government. Twitter's makeover could cost Elon Musk billions.

Portfolio Pulse from Akanksha Bakshi

July 25, 2023 | 11:24 am

ABBV

Health Canada has approved AbbVie's Rinvoq for moderately to severely active ulcerative colitis in adult patients who have demonstrated prior treatment failure. The approval is for the 45 mg induction dose and the 15 mg and 30 mg maintenance doses.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:15 am

BTCY

Biotricity Inc. is expanding its artificial intelligence (AI) technology development in the field of remote cardiac care. The company aims to improve patient outcomes and reduce healthcare costs.

Portfolio Pulse from Bill Haddad

July 25, 2023 | 11:14 am

STOK

Stoke Therapeutics has announced new safety and efficacy data from its STK-001 drug in two ongoing Phase 1/2A studies and the open-label extension study in children and adolescents with Dravet Syndrome. The data suggests clinical benefits.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:12 am

LRMR

The FDA has cleared Larimar Therapeutics' Phase 2 dose exploration trial of CTI-1601 for Friedreich's Ataxia to proceed to the 50 mg cohort. The initiation of an open-label extension trial with 25 mg daily dosing is expected in Q1 2024, with interim data expected in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:07 am

APLT

Applied Therapeutics announced that a pre-NDA meeting will be held this summer to discuss a potential NDA submission for AT-007.

Portfolio Pulse from Bill Haddad

July 25, 2023 | 11:06 am

HYMTF

Hyundai Motor Company has inaugurated a Joint Battery Research Center with Seoul National University (SNU). The partnership aims to advance battery technologies and will undertake 22 joint research projects, including lithium metal and solid-state batteries. Hyundai will invest over KRW 30 billion by 2030 to facilitate research at the center.

Portfolio Pulse from Shivani Kumaresan

July 25, 2023 | 11:05 am